ICON Public Limited Company Share Price & Technical Analysis
ICLR · $116.8 (+0.18%)
Healthcare / Diagnostics & Research
$116.8
+0.18%
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical stud…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
-2% return in May, 4% avg return in past 3 year May month.
-33% return in 2026, 10% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -2% | -40% | 5% | 7% | -2% | – | – | – | – | – | – | – | -33% |
| 25 | -6% | -2% | -3% | -14% | -9% | 12% | 17% | 6% | -1% | -2% | 9% | -1% | 7% |
| 24 | -7% | 22% | 5% | -12% | 9% | -3% | 4% | -2% | -10% | -23% | -5% | -1% | -22% |
| 23 | 17% | -2% | -5% | -9% | 11% | 18% | 1% | 4% | -6% | -1% | 9% | 6% | 44% |
| 22 | -14% | -11% | 2% | -7% | 2% | -2% | 12% | -10% | -12% | 8% | 7% | -10% | -36% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$9.37B
P/E ratio
16.23
52W high
$211.0
52W low
$66.57
Volume
3,83,745
Beta
1.23
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is ICON Public Limited Company share price today?
- ICON Public Limited Company (ICLR) last traded around $116.8 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ICLR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ICLR. Download the app for real-time alerts.
- How can I analyze ICON Public Limited Company stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.